Cell death pathways in pancreatitis and pancreatic cancer

Pancreatology

Volumn 4, Issue 6, 2004, Pages 567-586

  Gukovskaya, Anna S ^a,b   Pandol, Stephen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Apoptosis; Caspases; Mitochondrial dysfunction; Necrosis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INDUCING FACTOR; CALPAIN; CASPASE; CYTOCHROME C; DEATH RECEPTOR; DOXORUBICIN; ENDONUCLEASE; ETOPOSIDE; GEMCITABINE; GENISTEIN; GROWTH FACTOR; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXYGENASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; PROTEIN BCL 2; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P16; PROTEIN P53; QUERCETIN; RESVERATROL; SALAZOSULFAPYRIDINE; SALICYLATE SODIUM; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI;

APOPTOSIS; CANCER SURVIVAL; CELL DEATH; CELL FUNCTION; CELL PERMEABILIZATION; ENDOPLASMIC RETICULUM; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; HUMAN; INFLAMMATORY CELL; METASTASIS; MITOCHONDRION; MORBIDITY; MORTALITY; NECROSIS; NONHUMAN; PANCREAS CANCER; PANCREAS NECROSIS; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; WILD TYPE;

EID: 11844301338     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000082182     Document Type: Review

References (204)

1. Kerr JF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
2. Adams JM: Ways of dying: Multiple pathways to apoptosis. Genes Dev 2003;17:2481-2495.
3. Schultz DR, Harrington WJ Jr: Apoptosis: Programmed cell death at a molecular level. Semin Arthritis Rheum 2003;32:345-369.
4. Fiers W, Beyaert R, Declercq W, Vandenabeele P: More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 1999;18:7719-7730.
5. Jaattela M, Tschopp J: Caspase-independent cell death in T lymphocytes. Nat Immunol 2003;4:416-423.
6. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15:269-290.
7. Nunez G, Benedict MA, Hu Y, Inohara N: Caspases: The proteases of the apoptotic pathway. Oncogene 1998;17:3237-3245.
8. Walczak H, Krammer PH: The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000;256:58-66.
9. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-1687.
10. Gulbins E, Dreschers S, Bock J: Role of mitochondria in apoptosis. Exp Physiol 2003;88:85-90.
11. Scorrano L, Korsmeyer SJ: Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 2003;304:437-444.
12. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G: Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000;14:729-739.
13. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
14. Strasser A, O'Connor L, Dixit VM: Apoptosis signaling. Annu Rev Biochem 2000;69:217-245.
15. Lockshin RA, Zakeri Z: Caspase-independent cell deaths. Curr Opin Cell Biol 2002;14:727-733.
16. Vieira HL, Kroemer G: Pathophysiology of mitochondrial cell death control. Cell Mol Life Sci 1999;56:971-976.
17. Degli EM, Dive C: Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 2003;304:455-461.
18. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y: Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998;95:14681-14686.
19. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH: Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000;7:1166-1173.
20. Roucou X, Montessuit S, Antonsson B, Martinou JC: Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J 2002;368:915-921.
21. Leist M, Jaattela M: Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001;2:589-598.
22. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jaattela M: Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001;153:999-1010.
23. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ: Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000;106:1127-1137.
24. Bidere N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, Senik A: Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 2003;278:31401-31411.
25. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin XM, Turk V, Salvesen GS: Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001;276:3149-3157.
26. Kohli V, Madden JF, Bentley RC, Clavien PA: Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999;116:168-178.
27. Wang KK: Calpain and caspase: Can you tell the difference? Trends Neurosci 2000;23:20-26.
28. Altznauer F, Conus S, Cavalli A, Folkers G, Simon HU: Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 2004;279:5947-5957.
29. Proskuryakov SY, Konoplyannikov AG, Gabai VL: Necrosis: A specific form of programmed cell death? Exp Cell Res 2003;283:1-16.
30. Eguchi Y, Shimizu S, Tsujimoto Y: Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997;57:1835-1840.
31. Nicotera P, Leist M, Ferrando-May E: Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998;102-103:139-142.
32. Lee HC, Wei YH: Mitochondrial role in life and death of the cell. J Biomed Sci 2000;7:2-15.
33. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM: Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 1997;174:167-172.
34. Lemasters JJ, Qian T, Bradham CA, Brenner DA, Cascio WE, Trost LC, Nishimura Y, Nieminen AL, Herman B: Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J Bioenerg Biomembr 1999;31:305-319.
35. Sims JL, Berger SJ, Berger NA: Poly(ADP-ribose) polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5′-triphosphate pools in DNA-damaged cells: Mechanism of stimulation of unscheduled DNA synthesis. Biochemistry 1983;22:5188-5194.
36. Carson DA, Seto S, Wasson DB, Carrera CJ: DNA strand breaks, NAD metabolism, and programmed cell death. Exp Cell Res 1986;164:273-281.
37. Ha HC, Snyder SH: Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999;96:13978-13982.
38. Pieper AA, Verma A, Zhang J, Snyder SH: Poly(ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 1999;20:171-181.
39. LaPlaca MC, Zhang J, Raghupathi R, Li JH, Smith F, Bareyre FM, Snyder SH, Graham DI, McIntosh TK: Pharmacologic inhibition of poly( ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma 2001;18:369-376.
40. 2 but not apoptosis. Gastroenterology 1995;109:472-482.
41. Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salzman AL, Szabo C: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA 2000;97:10203-10208.
42. Herceg Z, Wang ZQ: Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol 1999;19:5124-5133.
43. Virag L, Scott GS, Cuzzocrea S, Marmer D, Salzman AL, Szabo C: Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly(ADP-ribose) synthetase activation. Immunology 1998;94:345-355.
44. Barnes PJ, Karin M: Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
45. Aggarwal BB: Apoptosis and nuclear factor-κB: A tale of association and dissociation. Biochem Pharmacol 2000;60:1033-1039.
46. Karin M, Lin A: NF-κB at the crossroads of life and death. Nat Immunol 2002;3:221-227.
47. Kucharczak J, Simmons MJ, Fan Y, Gelinas C: To be, or not to be: NF-κB is the answer - Role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003;22:8961-8982.
48. Deveraux QL, Reed JC: IAP family proteins - Suppressors of apoptosis. Genes Dev 1999;13:239-252.
49. Wymann MP, Zvelebil M, Laffargue M: Phosphoinositide 3-kinase signalling - Which way to target? Trends Pharmacol Sci 2003;24:366-376.
50. Franke TF, Kaplan DR, Cantley LC: PI3K: downstream AKTion blocks apoptosis. Cell 1997;88:435-437.
51. Burgering BM, Kops GJ: Cell cycle and death control: Long live forkheads. Trends Biochem Sci 2002;27:352-360.
52. Datta SR, Brunet A, Greenberg ME: Cellular survival: A play in three Akts. Genes Dev 1999;13:2905-2927.
53. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996;87:619-628.
54. Jaattela M: Escaping cell death: Survival proteins in cancer. Exp Cell Res 1999;248:30-43.
55. Jolly C, Morimoto RI: Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000;92:1564-1572.
56. Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G, Pagoulatos GN: Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1995;95:1854-1860.
57. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH: Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1995;95:1446-1456.
58. Hutter JJ, Mestril R, Tam EK, Sievers RE, Dillmann WH, Wolfe CL: Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 1996;94:1408-1411.
59. Radford NB, Fina M, Benjamin IJ, Moreadith RW, Graves KH, Zhao P, Gavva S, Wiethoff A, Sherry AD, Malloy CR, Williams RS: Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci USA 1996;93:2339-2342.
60. Lee SH, Kim M, Yoon BW, Kim YJ, Ma SJ, Roh JK, Lee JS, Seo JS: Targeted Hsp70.1 disruption increases infarction volume after focal cerebral ischemia in mice. Stroke 2001;32:2905-2912.
61. Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C: Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun 2003;304:505-512.
62. Hajnoczky G, Davies E, Madesh M: Calcium signaling and apoptosis. Biochem Biophys Res Commun 2003;304:445-454.
63. Demaurex N, Distelhorst C: Cell biology. Apoptosis - The calcium connection. Science 2003;300:65-67.
64. 2+: A control point for apoptosis. Science 2003;300:135-139.
65. Berridge MJ: The endoplasmic reticulum: A multifunctional signaling organelle. Cell Calcium 2002;32:235-249.
66. Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH: Cytochrome c binds to inositol-1,4,5-trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 2003;5:1051-1061.
67. Engedal N, Saatcioglu F: Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features. Prostate 2001;46:289-297.
68. Jones BE, Lo CR, Srinivasan A, Valentino KL, Czaja MJ: Ceramide induces caspase-independent apoptosis in rat hepatocytes sensitized by inhibition of RNA synthesis. Hepatology 1999;30:215-222.
69. Pettus BJ, Chalfant CE, Hannun YA: Ceramide in apoptosis: An overview and current perspectives. Biochim Biophys Acta 2002;1585:114-125.
70. Darios F, Lambeng N, Troadec JD, Michel PP, Ruberg M: Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: Role in initiation of cell death. J Neurochem 2003;84:643-654.
71. Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE, Geilen CC: Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett 2002;516:47-52.
72. Martindale JL, Holbrook NJ: Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 2002;192:1-15.
73. Lee YJ, Shacter E: Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999;274:19792-19798.
74. Lee YJ, Shacter E: Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 2000;29:684-692.
75. Topanzian M, Gorelick FS: Acute pancreatitis; in Yamada T, Alpers DH, Laine L, Owyang C, Powell DW (eds): Textbook of Gastroenterology. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 2121-2150.
76. Lerch MM, Gorelick FS: Early trypsinogen activation in acute pancreatitis. Med Clin North Am 2000;84:549-563, viii.
77. Steer ML: Early events in acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999;13:213-225.
78. He ZJ, Podkletnova I, Alho H, Sand J, Nordback I: Apoptosis in acute pancreatitis. Ann Chir Gynaecol 2000;89:65-67.
79. Walker NI: Ultrastructure of the rat pancreas after experimental duct ligation. I. The role of apoptosis and intraepithelial macrophages in acinar cell deletion. Am J Pathol 1987;126:439-451.
80. Walker NI, Winterford CM, Kerr JF: Ultrastructure of the rat pancreas after experimental duct ligation. II. Duct and stromal cell proliferation, differentiation, and deletion. Pancreas 1992;7:420-434.
81. Gukovskaya AS, Perkins P, Zaninovic V, Sandoval D, Rutherford R, Fitzsimmons T, Pandol SJ, Poucell-Hatton S: Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroenterology 1996;110:875-884.
82. Kaiser AM, Saluja AK, Sengupta A, Saluja M, Steer ML: Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol 1995;269:C1295-C1304.
83. Yasuda H, Kataoka K, Ichimura H, Mitsuyoshi M, Iida T, Kita M, Imanishi J: Cytokine expression and induction of acinar cell apoptosis after pancreatic duct ligation in mice. J Interferon Cytokine Res 1999;19:637-644.
84. Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG: Differential effects of caspase-1/interleukin-1β-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest 2001;81:1001-1013.
85. Fujimoto K, Hosotani R, Wada M, Lee J, Koshiba T, Miyamoto Y, Doi R, Imamura M: Ischemia-reperfusion injury on the pancreas in rats: Identification of acinar cell apoptosis. J Surg Res 1997;71:127-136.
86. Frossard JL, Rubbia-Brandt L, Wallig MA, Benathan M, Ott T, Morel P, Hadengue A, Suter S, Willecke K, Chanson M: Severe acute pancreatitis and reduced acinar cell apoptosis in the exocrine pancreas of mice deficient for the Cx32 gene. Gastroenterology 2003;124:481-493.
87. Scoggins CR, Meszoely IM, Wada M, Means AL, Yang L, Leach SD: p53-dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas. Am J Physiol 2000;279:G827-G836.
88. Gomez G, Lee HM, He Q, Englander EW, Uchida T, Greeley GH Jr: Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp Biol Med 2001;226:692-700.
89. Evans JD, Cornford PA, Dodson A, Greenhalf W, Foster CS, Neoptolemos JP: Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Pancreatology 2001;1:254-262.
90. Gukovskaya AS, Gukovsky I, Jung Y, Mouria M, Pandol SJ: Cholecystokinin induces caspase activation and mitochondrial dysfunction in pancreatic acinar cells. Roles in cell injury processes of pancreatitis. J Biol Chem 2002;277:22595-22604.
91. Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, Pandol SJ: Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-a. Role in regulating cell death and pancreatitis. J Clin Invest 1997;100:1853-1862.
92. Laine VJ, Nyman KM, Peuravuori HJ, Henriksen K, Parvinen M, Nevalainen TJ: Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells. Gut 1996;38:747-752.
93. Kimura K, Shimosegawa T, Abe R, Masamune A, Satoh A, Takasu A, Koizumi M, Toyota T: Low doses of lipopolysaccharide upregulate acinar cell apoptosis in cerulein pancreatitis. Pancreas 1998;17:120-126.
94. Gukovsky I, Reyes CN, Vaquero EC, Gukovskaya AS, Pandol SJ: Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol 2003;284:G85-G95.
95. Gukovsky I, Nam K, Cheng J, Pandol S, Gukovskaya A: Caspases and poly(ADP-ribose) polymerase regulate the balance between apoptosis and necrosis in experimental pancreatitis. Gastroenterology 2003;124:A502.
96. Beil M, Leser J, Lutz MP, Gukovskaya A, Seufferlein T, Lynch G, Pandol SJ, Adler G: Caspase 8-mediated cleavage of plectin precedes F-actin breakdown in acinar cells during pancreatitis. Am J Physiol 2002;282:G450-G460.
97. Schild L, Matthias R, Stanarius A, Wolf G, Augustin W, Halangk W: Induction of permeability transition in pancreatic mitochondria by cerulein in rats. Mol Cell Biochem 1999;195:191-197.
98. Luthen R, Niederau C, Grendell JH: Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats. Am J Physiol 1995;268:G592-G604.
99. Luthen RE, Niederau C, Ferrell LD, Grendell JH: Energy metabolism in mouse pancreas in response to different dosages of a CCK analogue. Pancreas 1995;11:141-146.
100. Ku Y, Sharif R, Dhaulakhandi D, Dawra R, Bhagat L, Saluja A: Inhibition of poly(ADPribose) polymerase attenuates the severity of caerulein-induced pancreatitis and associated lung injury by inhibition of NF-kB activation. Pancreas 2003;27:392.
101. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J: Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-781.
102. Van Acker GJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML: Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity. Am J Physiol 2002;283:G794-G800.
103. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ: Early NF-κB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998;275:G1402-G1414.
104. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM: NF-κB/Rel activation in cerulein pancreatitis. Gastroenterology 1999;116:420-430.
105. Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, Pandol SJ: Localized pancreatic NF-κB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol 2001;280:G1197-G1208.
106. Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD: NF-κB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 2002;122:448-457.
107. Singh VP, Saluja AK, Bhagat L, van Acker GJ, Song AM, Soltoff SP, Cantley LC, Steer ML: Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J Clin Invest 2001;108:1387-1395.
108. Gukovsky I, Cheng J, Nam K, Lee O, Lugea A, Fischer L, Penninger J, Pandol S, Gukovskaya A: Phosphatidylinositide 3-kinase γ regulates key pathologic responses to cholecystokinin in pancreatic acinar cells. Gastroenterology 2004;126:554-566.
109. Frossard JL, Bhagat L, Lee HS, Hietaranta AJ, Singh VP, Song AM, Steer ML, Saluja AK: Both thermal and non-thermal stress protect against caerulein-induced pancreatitis and prevent trypsinogen activation in the pancreas. Gut 2002;50:78-83.
110. Bhagat L, Singh VP, Hietaranta AJ, Agrawal S, Steer ML, Saluja AK: Heat shock protein 70 prevents secretagogue-induced cell injury in the pancreas by preventing intracellular trypsinogen activation. J Clin Invest 2000;106:81-89.
111. Bhagat L, Singh VP, Song AM, van Acker GJ, Agrawal S, Steer ML, Saluja AK: Thermal stress-induced Hsp70 mediates protection against intrapancreatic trypsinogen activation and acute pancreatitis in rats. Gastroenterology 2002;122:156-165.
112. Schafer C, Williams JA: Stress kinases and heat shock proteins in the pancreas: Possible roles in normal function and disease. J Gastroenterol 2000;35:1-9.
113. 2+ changes. J Biol Chem 2001;276:18742-18747.
114. Schoenberg MH, Buchler M, Beger HG: Oxygen radicals in experimental acute pancreatitis. Hepatogastroenterology 1994;41:313-319.
115. Yu JH, Lim JW, Namkung W, Kim H, Kim KH: Suppression of cerulein-induced cytokine expression by antioxidants in pancreatic acinar cells. Lab Invest 2002;82:1359-1368.
116. Schulz HU, Niederau C, Klonowski-Stumpe H, Halangk W, Luthen R, Lippert H: Oxidative stress in acute pancreatitis. Hepatogastroenterology 1999;46:2736-2750.
117. Sutton R, Criddle D, Raraty MG, Tepikin A, Neoptolemos JP, Petersen OH: Signal transduction, calcium and acute pancreatitis. Pancreatology 2003;3:497-505.
118. Voronina S, Longbottom R, Sutton R, Petersen OH, Tepikin A: Bile acids induce calcium signals in mouse pancreatic acinar cells: Implications for bile-induced pancreatic pathology. J Physiol 2002;540:49-55.
119. Petersen OH: Calcium signal compartmentalization. Biol Res 2002;35:177-182.
120. 2+ elevations and the mitochondrial permeability transition pore. J Cell Sci 2002;115:485-497.
121. Mooren FC, Hlouschek V, Finkes T, Turi S, Weber IA, Singh J, Domschke W, Schnekenburger J, Kruger B, Lerch MM: Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction. J Biol Chem 2003;278:9361-9369.
122. Sandoval D, Gukovskaya A, Reavey P, Gukovsky S, Sisk A, Braquet P, Pandol SJ, Poucell-Hatton S: The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996;111:1081-1091.
123. Gukovsky I, Blinman T, Zaninovic V, Jung Y, Gukovskaya A, Pandol S: Role of transcription factor NF-kB in mediating hormone-induced pancreatitis. Gastroenterology 1998;114:A465.
124. O'Neill S, O'Neill AJ, Conroy E, Brady HR, Fitzpatrick JM, Watson RW: Altered caspase expression results in delayed neutrophil apoptosis in acute pancreatitis. J Leukoc Biol 2000;68:15-20.
125. Salomone T, Tosi P, Raiti C, Guariento A, Tomassetti P, Migliori M, Saieva C, Romboli M, Gullo L: Apoptosis in the peripheral blood mononuclear cells as a self-limitation process in human acute pancreatitis. Pancreatology 2002;2:204-210.
126. Satoh A, Masamune A, Kimura K, Kaneko K, Sakai Y, Yamagiwa T, Satoh M, Kikuta K, Asakura T, Shimosegawa T: Nuclear factorκB expression in peripheral blood mononuclear cells of patients with acute pancreatitis. Pancreas 2003;26:350-356.
127. Denham W, Yang J, Fink G, Denham D, Carter G, Bowers V, Norman J: TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: A study in the perfused human pancreas. J Surg Res 1998;74:3-7.
128. Saluja A, Hofbauer B, Yamaguchi Y, Yamanaka K, Steer M: Induction of apoptosis reduces the severity of caerulein-induced pancreatitis in mice. Biochem Biophys Res Commun 1996;220:875-878.
129. Bhatia M, Wallig MA, Hofbauer B, Lee HS, Frossard JL, Steer ML, Saluja AK: Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis. Biochem Biophys Res Commun 1998;246:476-483.
130. Kaiser AM, Saluja AK, Lu L, Yamanaka K, Yamaguchi Y, Steer ML: Effects of cycloheximide on pancreatic endonuclease activity, apoptosis, and severity of acute pancreatitis. Am J Physiol 1996;271:C982-C993.
131. Reber H: Pancreatic Cancer, Pathogenesis, Diagnosis, and Treatment. Totowa, Humana Press, 1998.
132. Ozawa F, Friess H, Tempia-Caliera A, Kleeff J, Buchler MW: Growth factors and their receptors in pancreatic cancer. Teratog Carcinog Mutagen 2001;21:27-44.
133. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI, Korc M: Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-1856.
134. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289-5296.
135. Korc M: Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 1998;7:25-41.
136. Min Y, Adachi Y, Yamamoto H, Ito H, Itoh F, Lee CT, Nadaf S, Carbone DP, Imai K: Genetic blockade of the insulin-like growth factor-1 receptor: A promising strategy for human pancreatic cancer. Cancer Res 2003;63:6432-6441.
137. Vickers SM, MacMillan-Crow L, Huang Z, Thompson JA: Acidic fibroblast growth factor (FGF-1) signaling inhibits peroxynitriteinduced cell death during pancreatic tumorigenesis. Free Radic Biol Med 2001;30:957-966.
138. Yen TW, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH Jr: Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 2002;131:129-134.
139. Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maillet B, Kloppel G: Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer 1994;69:144-151.
140. Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maier A, Kloppel G, Liebe S, Kreuser ED: Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas 1996;12:248-259.
141. Vaquero EC, Edderkaoui M, Nam KJ, Gukovsky I, Pandol SJ, Gukovskaya AS: Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. Gastroenterology 2003;125:1188-1202.
142. Vaquero E, Edderkaoui M, Gukovsky I, Pandol S, Gukovskaya A: Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004;279:34643-34654.
143. Edderkaoui M, Vaquero E, Pandol S, Gukovskaya A: Extracellular matrix proteins stimulate reactive oxygen species production in human pancreatic cancer cells through non-mitochondrial NAD(P)H oxidase. Pancreas 2003;27:379.
144. Vaquero E, Nam K, Gukovsky I, Pandol S, Gukovskaya A: Non-mitochondrial NAD(P)H oxidase mediates growth factorinduced ROS production and suppression of apoptosis in pancreatic cancer cells. Gastroenterology 2003;124:A290.
145. Kornmann M, Ishiwata T, Kleeff J, Beger HG, Korc M: Fas and Fas-ligand expression in human pancreatic cancer. Ann Surg 2000;231:368-379.
146. Ibrahim SM, Ringel J, Schmidt C, Ringel B, Muller P, Koczan D, Thiesen HJ, Lohr M: Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Pancreas 2001;23:72-79.
147. Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR, Evers BM: Selective targeting of the nuclear factor-κB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery 2002;132:127-134.
148. Trauzold A, Wermann H, Arlt A, Schutze S, Schafer H, Oestern S, Roder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H: CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene 2001;20:4258-4269.
149. Glazyrin AL, Chinni S, Alhasan S, Adsay VN, Vaitkevicius VK, Sarkar FH: Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis. Int J Oncol 2002;20:201-205.
150. Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D, Kami K, Mori T, Fujimoto K, Doi R, Imamura M: Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 2003;106:17-25.
151. Gerhard MC, Schmid RM, Hacker G: Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br J Cancer 2002;86:893-898.
152. Wolf BB, Schuler M, Li W, Eggers-Sedlet B, Lee W, Tailor P, Fitzgerald P, Mills GB, Green DR: Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 2001;276:34244-34251.
153. Friess H, Lu Z, Graber HU, Zimmermann A, Adler G, Korc M, Schmid RM, Buchler MW: Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 1998;43:414-421.
154. Graber HU, Friess H, Zimmermann A, Korc M, Adler G, Schmid R, Buchler MW: Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells. J Gastrointest Surg 1999;3:74-80.
155. Trauzold A, Schmiedel S, Roder C, Tams C, Christgen M, Oestern S, Arlt A, Westphal S, Kapischke M, Ungefroren H, Kalthoff H: Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells. Br J Cancer 2003;89:1714-1721.
156. Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL: Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br J Cancer 2000;83:1380-1386.
157. Bold RJ, Virudachalam S, McConkey DJ: Bcl-2 expression correlates with metastatic potential in pancreatic cancer cell lines. Cancer 2001;92:1122-1129.
158. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ: The nuclear factor-κB/RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-127.
159. Greten FR, Weber CK, Greten TF, Schneider G, Wagner M, Adler G, Schmid RM: Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 2002;123:2052-2063.
160. Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM: Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer. Int J Cancer 2003;105:735-746.
161. Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ: Inhibition of constitutive NF-κB activity by IκBa M suppresses tumorigenesis. Oncogene 2003;22:1365-1370.
162. Shah SA, Potter MW, McDade TP, Ricciardi R, Perugini RA, Elliott PJ, Adams J, Callery MP: 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J Cell Biochem 2001;82:110-122.
163. Nawrocki ST, Bruns CJ, Harbison MT, Bold RJ, Gotsch BS, Abbruzzese JL, Elliott P, Adams J, McConkey DJ: Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther 2002;1:1243-1253.
164. Nagasaki K, Schem C, von Kaisenberg C, Biallek M, Rosel F, Jonat W, Maass N: Leucine-zipper protein, LDOC1, inhibits NF-κB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 2003;105:454-458.
165. Bondar VM, Sweeney-Gotsch B, Andreeff M, Mills GB, McConkey DJ: Inhibition of the phosphatidylinositol 3)-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther 2002;1:989-997.
166. Matsumoto J, Kaneda M, Tada M, Hamada J, Okushiba S, Kondo S, Katoh H, Moriuchi T: Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells. Jpn J Cancer Res 2002;93:1317-1326.
167. Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR, Schafer H: Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003;22:3243-3251.
168. Fahy BN, Schlieman M, Virudachalam S, Bold RJ: AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2. Br J Cancer 2003;89:391-397.
169. Katayose K, Seki T, Ohba N, Funatomi H, Goto N, Mitamura K: Growth-inhibitory effect of phosphatidylinositol 3-kinase inhibitor on human pancreatic cancer cells and expression of Bcl-2 family. Anticancer Res 2003;23:2383-2387.
170. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-554.
171. Ghaneh P, Kawesha A, Evans JD, Neoptolemos JP: Molecular prognostic markers in pancreatic cancer. J Hepatobiliary Pancreat Surg 2002;9:1-11.
172. Tsuchida T, Kijima H, Hori S, Oshika Y, Tokunaga T, Kawai K, Yamazaki H, Ueyama Y, Scanlon KJ, Tamaoki N, Nakamura M: Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma. Cancer Gene Ther 2000;7:373-383.
173. Tong WG, Ding XZ, Witt RC, Adrian TE: Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 2002;1:929-935.
174. Ding XZ, Hennig R, Adrian TE: Lipoxygenase and cyclooxygenase metabolism: New insights in treatment and chemoprevention of pancreatic cancer. Mol Cancer 2003;2:10.
175. Ding XZ, Tong WG, Adrian TE: 12-Lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int J Cancer 2001;94:630-636.
176. Ding XZ, Kuszynski CA, El Metwally TH, Adrian TE: Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. Biochem Biophys Res Commun 1999;266:392-399.
177. Avis I, Hong SH, Martinez A, Moody T, Choidy T, Choi YH, Trepel J, Das R, Jett M, Mulshine JL: Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 2001;15:2007-2009.
178. Ghosh J: Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase. Biochem Biophys Res Commun 2003;307:342-349.
179. Szekeres CK, Tang K, Trikha M, Honn KV: Eicosanoid activation of extracellular signalregulated kinase1/2 in human epidermoid carcinoma cells. J Biol Chem 2000;275:38831-38841.
180. Bonizzi G, Piette J, Merville MP, Bours V: Cell type-specific role for reactive oxygen species in nuclear factor-κB activation by interleukin-1. Biochem Pharmacol 2000;59:7-11.
181. Vousden KH, Lu X: Live or let die: The cell's response to p53. Nat Rev Cancer 2002;2:594-604.
182. 1 fibronectin receptor. J Cell Biol 2000;150:1467-1478.
183. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-856.
184. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C: Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662-668.
185. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N: MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 2000;79:355-369.
186. Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, Reber HA, Pandol SJ: Foodderived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer 2002;98:761-769.
187. Buchler P, Gukovskaya AS, Mouria M, Buchler MC, Buchler MW, Friess H, Pandol SJ, Reber HA, Hines OJ: Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas 2003;26:264-273.
188. Xu Z, Friess H, Solioz M, Aebi S, Korc M, Kleeff J, Buchler MW: Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine. Int J Cancer 2001;94:268-274.
189. Sato T, Odagiri H, Ikenaga SK, Maruyama M, Sasaki M: Chemosensitivity of human pancreatic carcinoma cells is enhanced by IκBa super-repressor. Cancer Sci 2003;94:467-472.
190. McDade TP, Perugini RA, Vittimberga FJ Jr, Carrigan RC, Callery MP: Salicylates inhibit NF-κB activation and enhance TNF-α-induced apoptosis in human pancreatic cancer cells. J Surg Res 1999;83:56-61.
191. Eibl G, Wente MN, Reber HA, Hines OJ: Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 2001;287:522-529.
192. Muerkoster S, Arlt A, Witt M, Gehrz A, Haye S, March C, Grohmann F, Wegehenkel K, Kalthoff H, Folsch UR, Schafer H: Usage of the NF-κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer 2003;104:469-476.
193. Ng SSW, Tsao MS, Chow S, Hedley DW: Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res 2000;60:5451-5455.
194. Xing HR, Cordon-Cardo C, Deng X, Tong W, Campodonico L, Fuks Z, Kolesnick R: Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat Med 2003;9:1266-1268.
195. Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE: Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. Cancer Res 2001;61:8758-8768.
196. Dempke WC: Farnesyl transferase inhibitors - A novel approach in the treatment of advanced pancreatic carcinomas. Anticancer Res 2003;23:813-818.
197. Caponigro F, Casale M, Bryce J: Farnesyl transferase inhibitors in clinical development. Expert Opin Investig Drugs 2003;12:943-954.
198. Blanchard JA, Barve S, Joshi-Barve S, Talwalker R, Gates LK Jr: Antioxidants inhibit cytokine production and suppress NF-κB activation in CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci 2001;46:2768-2772.
199. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, Oberley LW: The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 2003;63:1297-1303.
200. Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, Lemoine NR, Neoptolemos JP: Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Gene Ther 2001;8:199-208.
201. Mohiuddin M, Chendil D, Dey S, Alcock RA, Regine W, Mohiuddin M, Ahmed MM: Influence of p53 status on radiation and 5-fluorouracil synergy in pancreatic cancer cells. Anticancer Res 2002;22:825-830.
202. Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR Jr, Salhab KF, McGrath P, Strodel W, Freeman JW: Differential expression of transforming growth factor-β receptors in human pancreatic adenocarcinoma. Anticancer Res 2000;20:43-51.
203. Ahmed MM, Alcock RA, Chendil D, Dey S, Das A, Venkatasubbarao K, Mohiuddin M, Sun L, Strodel WE, Freeman JW: Restoration of transforming growth factor-β signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2. J Biol Chem 2002;277:2234-2246.
204. Cotter T, Martin S: Techniques in Apoptosis. London, Portland Press, 1996.